Study of Regorafenib in Patients With Advanced Myeloid Malignancies

NCT03042689 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Regorafenib

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]